UK Prices See A Raft Of Rises In November
Pricewatch UK – November 2022
Multiple treble-digit price rises were seen for UK generics in November as a lengthy list of price concessions was issued by the Department of Health and Social Care.
You may also be interested in...
UK Prices Double For Multiple Molecules In December
Average trade prices for multiple products more than doubled in December in the UK, according to the latest figures from market researcher WaveData.
Celltrion And Rani Partner For Oral Adalimumab
Celltrion has doubled down on its alliance with Rani Therapeutics for oral pill versions of biosimilars by adding adalimumab to an existing collaboration covering ustekinumab.
MGC And GlycoNex Kick Off Denosumab Trial In Japan
Mitsubishi Gas Chemical Company and GlycoNex have begun a Phase I trial in Japan for their SPD8 denosumab biosimilar. The partners are also “actively pursuing global development plans” for the rival to Prolia and Xgeva.